Disciplined Investments, LLC Biocryst Pharmaceuticals Inc Transaction History

Disciplined Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 10, 2023	BUY	$6.96 - $8.81 $76 - $96	11 Added 157.14%	18 $0
Q1 2023 May 10, 2023	SELL	$7.94 - $11.84 $87 - $130	-11 Reduced 61.11%	7 $0
Q4 2022 Feb 01, 2023	SELL	$10.5 - $14.2 $21 - $28	-2 Reduced 10.0%	18 $0
Q3 2022 Nov 03, 2022	BUY	$10.79 - $14.81 $161 - $222	15 Added 300.0%	20 $0
Q2 2022 Aug 09, 2022	SELL	$7.89 - $17.88 $55 - $125	-7 Reduced 58.33%	5 $0
Q1 2022 Apr 22, 2022	BUY	$11.56 - $19.76 $138 - $237	12 New	12 $0

280

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.39B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Disciplined Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Disciplined Investments, LLC with notifications on news.